Research on evaluation index system of post-market value of proprietary Chinese medicine based on Delphi method
Objective Based on the characteristics of traditional Chinese medicine(TCM)and the expert consensus on the core indicators of the evaluation of the whole life Cycle Value of proprietary Chinese medicine(PCM)published by the team,the post-market value evaluation of proprietary Chinese medicine was quantitatively carried out.Methods The weight of the value evaluation index of PCM after listing was determined by using Delphi expert consultation method combined with analytic hierarchy process(AHP)through 26 experts and two rounds of consultation.Results Expert positive coefficient,authority degree and Kendall coordination coefficient were 88.46％and 100％,0.86 and 0.84,0.231 and 0.234,respectively,and the coefficient of variation among each index ranged from 0.071 to 0.262.Finally,a quantitative value evaluation index system including seven evaluation dimensions and 51 evaluation indexes was formed after the listing of proprietary Chinese medicines.Weights respectively as"32.42％security and risk management","effectiveness 25.65％","15.62％drug quality","9.21％accessibility"and"7.71％suitability","5.53％innovative"and"3.85％ cost".Conclusion This study not only further clarified the core elements of value evaluation of proprietary Chinese medicines after listing,but also provided effective support for accurate evaluation of the value connotation and advantages of different proprietary Chinese medicines.
Chinese patent medicinevalue assessmentpost-marketDelphi methodanalytic hierarchy process
NETL
NSTL
万方数据
